Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvano Adami

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2014
The role of interleukin-17A in psoriatic diseaseSilvano Adami, Andrea Cavani, Francesco Rossi, et al.
Expert Opinion on Pharmacotherapy|September 12, 2015
The use of bisphosphonates in women: when to use and when to stopDavide Gatti, Silvano Adami, Ombretta Viapiana, et al.
Aging Clinical and Experimental Research|December 10, 2003
Injectable bisphosphonates in the treatment of postmenopausal osteoporosisLeonardo Sartori, Silvano Adami, Paolo Filipponi, et al.
Autoimmune Diseases|August 25, 2012
Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complicationPaola Caramaschi, Domenico Biasi, Ilaria Dal Forno, et al.
European Journal of Endocrinology|February 25, 2006
Influence of two different GH dosage regimens on final height, bone geometry and bone strength in GH-deficient childrenGiorgio Radetti, Gianluca D'Addato, Davide Gatti, et al.
Expert Opinion on Pharmacotherapy|May 9, 2013
Osteoporosis treatment: why ibandronic acid?Maurizio Rossini, Giovanni Orsolini, Silvano Adami, et al.
Bone Research|August 15, 2015
Osteoporosis Treatment: When to Discontinue and When to Re-startSilvano Adami, Luca Idolazzi, Elena Fracassi, et al.
Expert Opinion on Drug Safety|December 25, 2015
Safety issues and adverse reactions with osteoporosis managementMaurizio Rossini, Giovanni Adami, Silvano Adami, et al.
Bone|November 21, 2007
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intakeSilvano Adami, Ombretta Viapiana, Davide Gatti, et al.
Endocrine|February 5, 2015
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: prosMaurizio Rossini, Giovanni Orsolini, Ombretta Viapiana, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2014
The role of interleukin-17A in psoriatic diseaseSilvano Adami, Andrea Cavani, Francesco Rossi, et al.
Expert Opinion on Pharmacotherapy|September 12, 2015
The use of bisphosphonates in women: when to use and when to stopDavide Gatti, Silvano Adami, Ombretta Viapiana, et al.
Aging Clinical and Experimental Research|December 10, 2003
Injectable bisphosphonates in the treatment of postmenopausal osteoporosisLeonardo Sartori, Silvano Adami, Paolo Filipponi, et al.
Autoimmune Diseases|August 25, 2012
Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complicationPaola Caramaschi, Domenico Biasi, Ilaria Dal Forno, et al.
European Journal of Endocrinology|February 25, 2006
Influence of two different GH dosage regimens on final height, bone geometry and bone strength in GH-deficient childrenGiorgio Radetti, Gianluca D'Addato, Davide Gatti, et al.
Expert Opinion on Pharmacotherapy|May 9, 2013
Osteoporosis treatment: why ibandronic acid?Maurizio Rossini, Giovanni Orsolini, Silvano Adami, et al.
Bone Research|August 15, 2015
Osteoporosis Treatment: When to Discontinue and When to Re-startSilvano Adami, Luca Idolazzi, Elena Fracassi, et al.
Expert Opinion on Drug Safety|December 25, 2015
Safety issues and adverse reactions with osteoporosis managementMaurizio Rossini, Giovanni Adami, Silvano Adami, et al.
Bone|November 21, 2007
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intakeSilvano Adami, Ombretta Viapiana, Davide Gatti, et al.
Endocrine|February 5, 2015
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: prosMaurizio Rossini, Giovanni Orsolini, Ombretta Viapiana, et al.
Pageof 13